Prognosis, Monitoring, and Daily Life

Living with IgA Nephropathy (IgAN) is often a marathon, not a sprint. Because the disease can span decades, understanding your long-term outlook and how to monitor it effectively is the best way to regain a sense of control over your health ^[1].

Understanding Your Long-Term Outlook

One of the most important things to know is that a diagnosis of IgAN does not mean kidney failure is inevitable. The course of the disease is highly variable:

• The Statistics: Research shows that roughly 30% to 45% of patients may progress to kidney failure over a period of 20 to 25 years ^[1][2].
• The Positive Side: This means that more than half of people with IgAN do not reach kidney failure within that timeframe, especially with modern treatments ^[3].

To help personalize this, doctors use the International IgAN Prediction Tool. This tool combines your biopsy results (MEST-C score) with your age, kidney function (eGFR), and protein levels at the time of diagnosis to estimate the statistical risk of a composite outcome (such as a 50% decline in eGFR or progressing to kidney failure) over a specified time horizon ^[4][5]. It is important to remember that this tool is a guide, not a guarantee. It was built using data from older studies, and newer treatments like SGLT2 inhibitors and targeted therapies may result in better outcomes than the tool predicts ^[6].

The Pillars of Long-Term Monitoring

You and your care team will track several “markers” to see how well your kidneys are doing. Consistency is more important than any single result.

• eGFR (estimated Glomerular Filtration Rate): This measures how well your kidneys are filtering waste. Doctors look at the slope (the trend over months and years) rather than a single day’s number ^[7].
• UPCR or UACR (Proteinuria): These urine tests measure how much protein you are leaking. Lowering your protein is the most effective way to slow the disease. While targets vary, many specialists aim for below 0.5 g/day ^[8][9].
• Home Blood Pressure: High blood pressure is a silent “accelerant” for kidney damage. Tracking your pressure at home helps your doctor adjust your medications accurately. Your clinician will set a target for you—often aiming for a properly measured clinic systolic blood pressure below 120 mm Hg when tolerated ^[10].

Daily Life and Practical Management

Managing IgAN happens in your kitchen and medicine cabinet just as much as in the doctor’s office.

• The Sodium Limit: Excess salt makes your blood pressure medications less effective and increases the strain on your kidneys. Aim for less than 2 grams of sodium per day (about one level teaspoon of salt) ^[11].
• Avoid NSAIDs: Over-the-counter pain relievers like ibuprofen (Advil, Motrin) and naproxen (Aleve) are nephrotoxic, meaning they can be toxic to the kidneys. They can cause a sudden drop in kidney function, especially during a flare-up, with dehydration, or alongside blood pressure drugs ^[11]. Always ask your clinician before using them. Acetaminophen (Tylenol) is often preferred at recommended doses, but it still carries liver toxicity risks and maximum dose limits, especially with alcohol or combination products.
• Managing “Lab Anxiety”: It is normal to feel anxious before blood work. Many patients find it helpful to focus on their “controllables”—diet, blood pressure, and medication—rather than the numbers alone.

Building Your Care Team

Because IgAN is a specialized “primary glomerular disease,” it is often beneficial to see a nephrologist who has a specific interest or expertise in this area ^[12]. A specialist can help you weigh the risks of newer immunosuppressants and keep you informed about clinical trial opportunities.

When vetting a doctor, you might ask:

• “How many patients with IgA Nephropathy do you currently manage?”
• “Are you familiar with the newest targeted therapies like sparsentan or targeted-release budesonide?”
• “Does your clinic participate in clinical trials for new kidney treatments?”

By staying proactive and informed, you can navigate the complexities of IgAN and focus on living a full, active life.